2022年全国中药材及饮片质量分析概况OACSTPCD

In early 2022,the State Council's General Office issued the 14th Five-Year Plan for Traditional Chinese Medicine Development,which outlines specific requirements to strengthen the safety regulation of Chinese medicine,enhance the capability to evaluate Chinese medicine quality,establish a comprehensive Chinese medicine quality safety supervision mechanism,and strengthen the management of the sources of Chinese medicine decoction pieces,aiming at promoting the high-quality development of the Chinese medicine industry.In 2022,under the leadership and organization of the National Medical Products Administration and provincial drug supervision and management departments,the nationwide results of inspections of Chinese medicinal materials and decoction pieces continued to be summarized.The data from inspections conducted in 31 provinces,autonomous regions,and municipalities were analyzed to assess the overall quality situation,the overall pass rate was 98%.Relevant regulatory strategies and recommendations were proposed to address quality and standard issues,thereby providing big data support to improve standards of Chinese medicinal materials and decoction pieces and enhance regulatory effectiveness and capabilities.